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Abstract
Problem: 5% human albumin is used very frequently in the hospital setting with
hypotensive post-surgical patients. There are associated risks with the use of
human albumin and it has been shown that normal saline is at least as effective in
treating extreme hypotension in this patient population.
Significance: Associated risks that are present with the use of human albumin
may be equal to those of the risks of whole blood transfusions. In addition weight
gain and fluid retention are complications associated with the use of human
albumin versus the use of normal saline. Furthermore, human albumin costs
$40.59 more than normal saline solution.
Methods: Literature review and the IOWA Model.
Results: Patients who are not at risk for post-perfusion syndrome, pulmonary
hypertension, on strict intake and output regulation, or increased vascular
permeability and are experiencing hypotension secondary to hypovolemia postoperatively would benefit from normal saline as a first line therapy.
Key words: hypotension, fluid resuscitation, fluid loss, hypovolemia, cost,
safety, post-operative, colloid, crystalloid, human
albumin, 5% albumin, normal saline, saline
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hypotensive episodes, I analyzed and utilized the evidence to develop an evidence-based
recommendation for surgeons to consider. In the next chapter, I discussed the model
which was used to structure my project.
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Chapter Two: Model
Chapter Two: Model
Iowa Model
Iowa Model
The Iowa Model of Evidence-Based Practice to Promote Quality Care is a useful
The Iowa Model of Evidence-Based Practice to Promote Quality Care is a useful
model for the nurses to follow in order to know how to begin, develop, and assess
model for the nurses to follow in order to know how to begin, develop, and assess
evidence-based practice (Burns & Grove, 2009). This model can be used to help nurses
evidence-based practice (Burns & Grove, 2009). This model can be used to help nurses
make daily decisions in the care of their patients. The Iowa Model provides a framework
make daily decisions in the care of their patients. The Iowa Model provides a framework
allowing for all members of the healthcare team to be included in the quality change. For
allowing for all members of the healthcare team to be included in the quality change. For
this reason, I chose this model. It allows the change to be a team effort and increases the
this reason, I chose this model. It allows the change to be a team effort and increases the
likelihood of a successful implementation a successful implementation (Burns & Grove,
likelihood of a successful implementation a successful implementation (Burns & Grove,
2009).
2009).
There are seven steps in the Iowa model (Doody, C.M, & Doody, O.,2001). The
There are seven steps in the Iowa model (Doody, C.M, & Doody, O.,2001). The
first step is to select a topic. The topic should be a trigger for needed change such as a
first step is to select a topic. The topic should be a trigger for needed change such as a
clinical problem. Changes are necessary to keep nursing practices current. The use of the
clinical problem. Changes are necessary to keep nursing practices current. The use of the
best evidence to provide effective and cost-appropriate treatment is the goal of the
best evidence to provide effective and cost-appropriate treatment is the goal of the
changing current practices. The topic should have a large amount of data and evidence in
changing current practices. The topic should have a large amount of data and evidence in
the area of need. Forming a team is the second step in the Iowa model. The team should
the area of need. Forming a team is the second step in the Iowa model. The team should
consist of at least one person under the guidance of a committee. Team responsibilities
consist of at least one person under the guidance of a committee. Team responsibilities
include development, implementation, and evaluation of the EBP. (Doody, et al.,2001).
include development, implementation, and evaluation of the EBP. (Doody, et al.,2001).
The third step is evidence retrieval. This is simply searching for the evidence
The third step is evidence retrieval. This is simply searching for the evidence
necessary to address the problem of focus and then to use the evidence to recommend
necessary to address the problem of focus and then to use the evidence to recommend
change the current practice. There must be sufficient data to support the propose change.
change the current practice. There must be sufficient data to support the propose change.
3

A paucity in the literature would indicate the topic is not appropriate for an evidencebased project, but for a research thesis. Grading the evidence is the fourth step and allows
the person developing the project to evaluate the effectiveness, appropriateness, and the
feasibility of an appropriate outcome (Doody, et al.,2001).
The fifth step is to develop the evidence-based recommendation standard: “This
sets the standard of practice guidelines, assessments, actions, and treatment as required”
(Doody, et al.,2001). The recommendation that I developed included both the pros and
cons found in the literature. The standard should be supported by the pros, but caregivers
need to be aware of the limitations of the treatment to provide efficient care.
The sixth step is to implement the recommendation. This step requires interaction
between all levels of care. Management and direct care employees need to be trained with
the new practice and the new recommendation by a member of the committee. If workers
understand the benefits of this change, they will be more likely to comply with the new
recommendation (Doody, et al.,2001). The seventh and final step is to evaluate the
project’s level of change and value. Ultimately this step is used to see how well the
project was implemented and to achieve a solution to the problem trigger (Burns &
Grove, 2009).
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Chapter Three: Framework
Synthesis of Data Retrieval
To complete the review of literature, I began on the Cedarville University
Centennial Library’s website. I used the “multiple databases” tab to select the following
databases: CINAHL Plus with Full Text, Cochrane Central Register of Controlled Trials,
and Cochrane Database of Systematic Reviews. The advanced search tab allowed me to
narrow down my findings. I did not select the option for “results with full text” as this
may have excluded articles that could be requested from other libraries.
I also selected the “peer reviewed” and “evidenced-based” article options, and the
initial timeline was set to gather articles from within the last five years. The timeline
eventually expanded to 10 years, with the exception of one article. This article was
repeatedly listed as a reference in current articles, indicating its validity for current
research. Once I had reviewed the articles, I checked their references for additional
articles and searched for those which were relevant.
Search Terminologies
I used the following terms to narrow the evidence findings: “hypotension”, “low
blood pressure”, “post-surgical”, “fluid loss”, “hypovolemia”, “cost”, “treatment”,
“therapy”, “illness”, “guidelines” and “adverse effects” in combination with either
“human albumin” or “normal saline”. I also used the following as substitute terms for
normal saline: “saline”, “0.9% saline”, and “crystalloid”. For “5% human albumin”, I
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substituted the terms “human albumin”, “albumin”, “5% albumin” and “colloid”. Not
every search needed to include human albumin and normal saline together. I was able to
gather research data that was related to one or the other and gain insightful data about that
solution.
Inclusion & Exclusion Data
The inclusion data is very broad. The patients must be hospitalized, living, adult
humans, of any race or any gender. The unit in which the recommendation was presented
was an adult cardio-thoracic care unit. The patient population consisted of postoperative
adults and included a high level of patients for whom strict intake and output regulation
was monitored. Currently, 5% human albumin is given for hypotension secondary to
hypovolemia for most patients. While this recommendation is based on the surgeon’s
preference, patients recovering from a coronary artery bypass graft may have two bottles
of 5% human albumin for a total of 500 ml per standing order to treat mean arterial
pressures lesser than sixty mm Hg or for urine output less than thirty mL over one hour.
Articles were considered from all countries, as inclusion of only articles from the United
States would have considerably limited the search results. The articles needed to include
the administration of 5% human albumin and/or normal saline to a patient. I considered
articles that included either normal saline or 5% human albumin even if the title did not
mention a hypotensive situation. As a result, I was able to review a broader base of
literature.
I excluded articles unrelated to in-patient related fluid replacement therapy. I also
excluded articles that were not published or updated in the last ten years, except for the
article that was repeatedly referenced by current articles. If the article did not use adults
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only, the research was excluded. I did not initially account for sample size, but I
considered its impact during the evaluation of each article.
Ethical Considerations
I did not implement research on human subjects, and I did not need approval from
the Institutional Review Board (IRB). This final outcome of this evidenced-based
research project was based upon completed research to date. I did not actively collect
data with human participants.
Any negative effects regarding use of saline over human albumin or vice versa
that led to a negative outcome would have been an ethical dilemma. If the outcome of the
literature review had resulted in a possible negative outcome for the patient, I would not
have recommended that specific replacement therapy.
Specific Timeline
I needed to finish retrieving and grading evidence by March 14, 2013. I needed to
develop an evidence-based recommendation or recommendation and present it to my unit
Nurse Educator and stakeholder, Dawn Myers, by June 14, 2013. I met with one of the
hospital’s main cardiothoracic surgeon’s, Dr. Pavlina, MD on August 2, 2013. I met with
my Evidence Based Project Committee intermittently throughout this timeline.
Evidence Based Project Committee
Amy Voris, DNP, CNS, AOCN, Rachel Parrill, PhD, APHN-BC, Dawn Myers,
MSN, RN were on the committee of my evidenced- based project. They were a great
reference to facilitate the growth of my project and, in the end, successfully implement
my evidenced-based recommendation. In the subsequent chapter, I have outlined the
results of the literature review.
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Chapter Four: Literature Review & Results
Methodology
For this review of literature, I accessed the following databases: Cedarville
University CINAHL Plus with Full Text, Cochrane Central Register of Controlled Trials,
and Cochrane Database of Systematic Reviews. I used the following key words to
research related study reports, articles, and research studies:” hypotension”, “fluid
resuscitation”, “fluid loss”, “hypovolemia”, “cost”, “safety”, “post-operative”, “colloid”,
“crystalloid”, “human albumin”, “5% albumin”, “normal saline”, and “saline”. The time
frame of the literature search was about eight days, and twenty articles were found. Two
articles were not accessible through inter-library loan, and five articles were excluded
from the review. I have outlined inclusion and exclusion of articles in the next section.
Inclusion & Exclusion Data
Inclusion. Articles were required to have included patients that were postsurgical. Fluid resuscitation was also required as a treatment for hypotension. I preferred
studies that used either normal saline or 5% human albumin, but I considered all
crystalloids and colloids used for a more general outcome regarding the overall
classification. I focused on trends in cost, efficacy, and safety within the classes.
I also included studies that involved some but not all post-surgical patients were
included. The outcome of the study, however, needs to reflect the difference in risk
between post-surgical and non-post surgical patients in regard to fluid resuscitation. I
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included studies that used human albumin and normal saline on non-surgical patients
only if information regarding cost or safety (i.e., blood borne diseases) was included.
Exclusion. I excluded one article that included fluid resuscitation of a dialysis
patient with no presence of a recent surgery. I excluded four articles due to their focus on
the neonatal population.
Thirteen articles were reviewed, analyzed, and graded on their level of evidence
based on the Levels of Evidence for Primary Research Question criteria (Rahman &
Pukui, 2002). The grading criteria can be found in Appendix A. The results of the
analysis are listed below and are specified by author, year published, title, design of the
research, specific solutions compared, and the level of evidence.
Review of Literature
Fluid resuscitation is a common first-line treatment for hypotension related to
hypovolemia and results in a “rapid increase of cardiac output and tissue oxygenation”
(Trof, Sukul, Twusj, Girbes, & Groeneveld, 2010, p 697). Crystalloids and colloids are
the two types of fluid available. The patient’s specific necessities are the determinant of
which type of fluid is provided.
Crystalloids are fluids that are given to maintain electrolyte and fluid equilibrium
(Ignatavicius, D., & Workman, L, 2006). Ringer’s lactate and normal saline are common
crystalloids. Ringer’s lactate is a mixture of potassium, sodium, chloride, calcium, and
lactate that is dissolved in water. This solution is isotonic and is appropriate to be used to
expand volumes, and the added lactate is appropriate to buffer out acidosis. Normal
saline is a mixture of 0.9% sodium chloride and water. It is good for fluid replacement to
increase the intravascular volume. Crystalloids are good options for fluid
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replacement/expansion when there is no loss of red blood cells (Ignatavicius, et al.,
2006).
Colloids are fluids that contain protein and are given to reestablish osmotic
pressure and expand the intravascular fluid volume (Ignatavicius, et al., 2006). Colloids
include whole blood, packed red blood cells (PRBCs), plasma, plasma fractions, and
synthetic plasma expenders. Human albumin is a plasma protein fraction. Plasma protein
fractions and synthetic plasma expanders are given when hemoglobin and hematocrit are
within normal ranges and creates the benefit of an increase in osmotic pressure
(Ignatavicius, et al., 2006). A plasma protein fraction, such as human albumin 5%, is not
able to improve the oxygen-carrying function as whole blood or PRBCs can
(Ignatavicius, et al., 2006).
Efficacy, safety, and cost are analyzed in the subsequent sections. The summary
and limitations to the studies are successive to efficacy, safety, and cost with the literature
reviewed referenced in Table 1 and Table 2 in the conclusion of this section. Table 1
includes the literature reviewed that supports the use of Human Albumin in the adult
post-operative patient who is experiencing hypotension secondary to hypovolemia. Table
2 includes the literature reviewed that supports the use of Normal Saline in the adult postoperative patient who is experiencing hypotension secondary to hypovolemia.
Efficacy. Efficacy is defined as “the power to produce an effect” (MerriamWebster). The chosen treatment must have a positive effect for the patient and be at least
as or more efficient than alternative therapies. The effect of human albumin or normal
saline must create in increase of blood pressure in order to correct the hypotension
secondary to hypovolemia.
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The SAFE Study compared mortality rates of patients between those who
received 4% human albumin versus normal saline. These authors reported that human
albumin and normal saline resulted in similar outcomes at 28 days for ICU patients.
(Finfer, S., Bellomo, R., Boyce, N., French, J., Myburgh, J., & Norton, R. (The SAFE
Study Investigators), 2004). Although, these researchers used 4% albumin and not 5%
albumin this is not a significant variation. These researchers further report that 1) Net
intake of normal saline was not significantly greater than that of human albumin, 2) there
was no difference between groups on packed red blood cell use, and 3) central venous
pressures were higher in the human albumin group indicating a higher amount of
intravascular fluid. (Finfer,et al, 2004). This data supports that normal saline may be as
effective as human albumin for the treatment of hypotension secondary to hypovolemia.
When monitoring the hemodynamic variables of the post-op patient, 5% human
albumin has been found to have a greater volume expanding effect and a greater increase
in the cardiac index when compared to normal saline up to a maximum infusion of
1800ml (Verheij, J., Van Lingen, A., Beishuizen, A., Christiaans, H., De Jong, J., Girbes,
A., Groeneveld, A., 2006). Central Venous Pressures were increased by both solutions,
but normal saline was less effective than human albumin. (Verheij, et al., 2006).
Kruer and Ensor (2012) discussed the importance of the colloid osmotic pressure
(COP) and the length of time that the solution is retained in the intravascular system. The
safety of the patient may be considered in the length of efficacy of the solution. The
volume expanding properties of colloids remain effective for up to twenty fours hours
while the maximum benefit of crystalloids is four hours (Kruer et al., 2012).
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In post-operative patients, especially cardiac bypass patients, the risk for postperfusion syndrome (PPS) is high. Post perfusion syndrome causes a shift in the
intravascular fluid due to the inflammatory response prompted by the surgery (Kruer et
al., 2012). The histological changes show engorgement of the pulmonary vascular bed,
mircro-atelectasis and interstitial and alveolar hemorrhage. “Renal insufficiency,
neurologic changes and hemorrhagic diathesis are additional indications of postperfusion
syndrome” (Stoutenbeek, C., & Oudemans-van Straaten, H., 1990, p. 378). Use of a
crystalloid would only exacerbate this syndrome and result in excessive fluid in the
interstitial space. Patients at risk for third spacing benefitted from human albumin as the
need for blood transfusion was decreased (Diehl-Oplinger, L., & Kaminski, M. F. (2004).
Colloids, such as 5% human albumin, helped to maintain the colloid oncotic pressure and
decrease the chance of hypovolemia due to fluid shifting (Kruer et al., 2012).
In contrast, findings from Devlin & Berletta (2005) were that crystalloids have
been found to be more effective at volume expansion of intravascular and the interstitium
and to have a more rapid equilibrium than when compared to colloids. These results
argue that the use of a crystalloid results in a lower risk for pulmonary edema and
improving overall organ function. Colloids help to sustain and return the volume and
blood flow while normal saline and other crystalloids lower the concentration of the
plasma. A lower COP results in a diminished length of time that the volume is retained in
the intravascular system and is shifted into the interstitium (Trof, R., Sukul, S., Twisk, J.,
Girbes, A., & Groeneveld, A., 2010). This would theoretically result in more volumes of
a crystalloid be given. However, the Saline versus Albumin Fluid Evaluation Study
(SAFE) study mentioned above was only a ratio of infused human albumin vs. normal
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saline of 1:1.4. Mean arterial pressures responded similarly with the treatment of human
albumin and saline. This led to inconclusive evidenced-based findings (Finfer, et
al.,2004).
In distinction to the findings of the SAFE study, crystalloid solutions are more
likely to result in fluid overload because they are more quickly shifted into the
interstitium. According to Verheij, et al. (2006) there are conflicting studies about the
ratio of colloid to crystalloid needed. Verheij et al (2006) illuminated that cardiac and
vascular patients were not included in the SAFE study and that “the retention of albumin
is greater than that of saline after cardiac surgery, as inferred from measurements of
plasma and extravascular fluid volumes” (p. 1036). This highlights that the conclusions
found in the SAFE study are not applicable to patients who have undergone cardiac or
vascular surgeries as the research has not been completed to support them.
Safety. Albumin is a nonsynthetic solution and has been found to increase risk for
infections and allergic reaction (Kruer et al., 2012). Andrews (2011) outlined that human
albumin carries“…cost implications as well as the potential for transmission of bloodborne viral disease such as Creutzfeldt-Jakob Disease (CJD)” (p 136). Human albumin is
a blood protein and carries the risk for immune hypersensitivity, including anaphylactic
shock, viral disease transmission (HIV/AIDS, Hepatitis, etc.), prion disease transmission,
and possible increased edema formation once it is present in the interstitium (Robert &
Bratton, 2008; Fortin, Bassett, & Musini, 2010). Robert & Bratton clarify that prion
diseases and transmissible spongiform encephalopathy are always fatal (2008).
In difference, many clinicians have thought that human albumin administration
could reduce mortality in hypovolemic patients (Perel, P., & Roberts, I., 2012; Roberts,
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Blackhall, Bunn, & Schierhout, 2011). Vincent, Navickis, & Wilkes (2004) argued that
the use of human albumin reduced morbidity in critically ill patients. In another study,
5% human albumin did reduce mortality among cardiac surgery patients when compared
to crystalloid-only resuscitation (Kruer et al., 2012).
The average infusion ratio for human albumin to normal saline was 1:1.4. Despite
this ration, Perel (2012) stated that the risk of fluid overload of the patient was also no
longer a risk when compared to normal saline (p 5). Perel (2012) affirmed that the use of
human albumin over normal saline was not justifiable as human albumin does not
increase survival rate, there are additional risks compared to normal saline, and there is a
significant cost increase with human albumin.
Cost. In addition to safety and efficacy the expense of the solutions is a
significant factor when considering the appropriate use of human albumin versus normal
saline (Roberts et al., 2008; Talasaz, A., Jahangard-Rafsanjani, Z., Ziaie, S., Fahimi, F.,
2012). The national average cost of one 250ml vial of 5% human albumin is $41.00 (FFF
Enterprises, 2011). The cost of one 250ml bag of 0.9% normal saline is $1.30 (PMI,
2012). At this cost ratio, over 31 bags of 0.9% normal saline could be purchased and to
provide patient care for the cost of one 250ml vial of 5% human albumin. Kettering
Medical Center Network purchases the 250 ml 5% human albumin vials at $36.00 per
vial and the 250 mL bags of normal saline for $25.06 per case of 36 bags (Michelini,
2013). At this cost ratio, over 51 bags of 0.9% normal saline could be purchased for the
cost of one 250ml vial of 5% human albumin.
Talasaz et al (2012) concluded that albumin was a costly treatment that was being
used improperly. The researchers who conducted the SAFE Study indicated that the
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decision to use human albumin versus normal saline should take into consideration the
providers reference, cost, safety, and the individual needs of the patient (Finfer et al.
2004). This limits the ability to have a fixed recommendation. There must be a margin for
critical thinking and the best evidence practice for the individual needs of the patient.
Summary. To maximize the efficacy of the solutions used. Talasaz, et al (2012)
attempted to correlate the American Society of Hospital Pharmacist (ASHP)
recommendation with the relevance of human albumin usage. The study failed to
correlate albumin use with decreasing mortality rates, time in the hospital, length of time
needed on mechanical ventilation, or renal replacement therapies (Pettila & Ruokonen,
2005; Finfer, et al., 2004) Intensive care settings include most of the appropriate
situations for human albumin including but not limited to: hypervolemia, cardiac surgery,
acute respiratory distress syndrome (ARDS), organ transplant, and cerebral ischemia
patients (Talasaz, A., et al., 2012, 85-86).
Limitations. The SAFE study, which is the basis of many current fluid
resuscitation recommendations and research reviews was a very large study with
approximately 7,000 patients, though it excluded cardiac and vascular patients (Verheij,
et al., 2006). This excludes a wide span of the patient population that is administered
human albumin on a daily basis. There are a significant number of studies on the efficacy
and safety of human albumin versus normal saline but they have resulted in mixed
conclusions and with mostly small sample sizes and incomplete patient populations
(Devlin and Barletta, 2005).
Devlin, et al. was graded at a Level II of evidence and may result in a
recommendation of fair support of evidence. The Safe study written by Finfer, et al and
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the research completed by Verheij, et al. are graded as a Level I of evidence. While these
are both strong pieces of research they would separately be graded as an A or as being a
good recommendation that is supported. With conflicting or inconsistent research to
argue their points a recommendation of B or fair support of a recommendation would be
given. However, both articles are clear that the patient population and specific needs
should be analyzed prior to treatment. There is not a gold standard to eliminate the need
for individualization of care. Critical thinking and judgment should be used to develop
the best plan possible. For generalization purposes and when not focusing on one specific
patient population, normal saline can be used as the guideline recommendation as
evidenced by the SAFE study (Finfer, et al, 2004). This would be applicable to an A or of
good recommendation quality.
Both Level I and Level II articles bear mixed conclusions. The SAFE study
specifically outlined that if the patient does not fit generality to the study, i.e. cardiac or
vascular complications, the treatment choice should rely on outlying factors: “According
to the current state of knowledge, factors that may influence the choice of resuscitation
fluid for a critically ill patient include the individual clinician’s preference, the
tolerability of the treatment, its safety, and its cost” (Finfer, et al., 2004). This limits the
standardization of the recommendation of use of human albumin versus normal saline.
Evidenced Based Clinical Recommendations
Patients who are experiencing hypotension secondary to hypovolemia postoperatively, are not on strict intake and output regulation, and are not at risk for postperfusion syndrome, pulmonary hypertension, or increased vascular permeability would
benefit from receiving normal saline as a first line therapy. 5% human albumin would
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provide minimal benefit for these patients and risks associated with it would not be
justified. If the normal saline has failed to correct the hypotension, human albumin may
be used. This is a grade B recommendation. The levels of evidence presented are I and
III. This recommendation includes multiple meta-analyses but does not consist of a
randomized control trial or a non-randomized control trial. The strength of this
recommendation is of good scientific evidence.
Patients, who are at risk for the conditions listed above or are on strict intake and
output regulation, would benefit from receiving 5% human albumin as appropriate to the
patient’s specific needs in an effort to reduce the adverse effects of an increased vascular
permeability. Upon further research studies that include patients at risk for postperfusion syndrome, pulmonary hypertension, or increased vascular permeability with the
post-operative cardiac complicated background this conclusion may be manipulated.
Current research data suggests that there are no negative effects to the administration of
human albumin versus normal saline when the use is appropriately indicated. This is a
grade A recommendation. The Levels of Evidence presented are I, II & III and includes
three randomized control trials. The strength of this recommendation is of strong
scientific evidence. The next chapter will express the potential impact of these
recommendations and how they are perceived upon presentation.
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Literature Reviewed
Table 1
Literature reviewed which support the use of Human Albumin in the adult postoperative patient who is experiencing hypotension secondary to hypovolemia.
Level of
Authors &
Title
Design
Specific Solutions
Year
Compared
Evidence
published
Devliln &
Albumin for
Systematic
0.9 Normal Saline,
Level II
Barletta
fluid
Review
Lactated Ringers,
resuscitation:
Hetastarch, albumin, blood
2005
Implications
products
of the saline
versus
albumin fluid
evaluation.
DiehlOplinger &
Kaminiski

Choosing the
right fluid to
counter.

Case Series

0.9 Normal Saline, 0.45%
Level IV
Saline, Sodium Chloride
(3&5%) D5W, Lactated
Ringers, Dextrose
Solutions
(20%,40%,50%,60%,70%),
Human Albumin 5% &
25%

2004

Finfer,
Bellomo,
Boyce,
French,
Myburgh &
Norton
2004
Kruer &
Ensor

A comparison Randomized
of albumin
Control
and saline for Trial
fluid
resuscitation
in the
intensive care
unit.

Normal Saline,
4% Human Albumin

Level I

Colloids in
the intensive
care unit.

Normal saline 0.9%,
Lactated Ringers, Gelatin
4%, Hydroxyethyl starch
6%, Albumin 5%, Dextran.

Level II

Systematic
Review

2012
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Verheij,
Lingen,
Beishuizen,
Christiaans,
Jong,
Girbes,
Wisselink,
Rauwerda,
Huybregts,
&
Groeneveld

Cardiac
response is
greater for
colloid than
saline fluid
loading after
cardiac or
vascular
surgery.

Singlecentre, single
blinded,
randomized
clinical trial

Saline 0.9%, Gelatin 4%,
Hydroxyethyl starch 6%,
Albumin 5%

Level I

Greater
cardiac
response of
colloid than
saline fluid
loading in
septic and
non-septic
critically ill
patients with
clinical
hypovolemia.

Singlecentre, single
blinded,
randomized
clinical trial

Saline 0.9%, Gelatin 4%,
Hydroxyethyl starch 6%,
Albumin 5%

Level I

2006
Trof, Sukul,
Twish,
Girbes, &
Groeneveld
2010

Talasaz,
JahangardRafsanjani,
Ziaie, &
Fahimi
2012
Roberts &
Bratton
1998

Evaluation of Retrospective Human Albumin
the pattern of Comparative
human
Study
albumin
utilization at a
university
hospital.

Level III

Colloid
volume
expanders:
Problems,
pitfalls, and
possibilities.

Level II

Systematic
Review

Human Albumin 5% &
25%, Dextran 40 & 70,
Gelatin 4%, Hetastarch,
Pentastrach
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Table 2
Literature reviewed which support the use of Normal Saline in the adult postoperative patient who is experiencing hypotension secondary to hypovolemia.

Authors &
Year
published

Title

Design

Specific
Solutions
Compared

Level of
Evidence

Roberts,
Blackhall,
Alderson,
Bunn,
Schierhout

Human albumin
solution for
resuscitation and
volume
expansion in
critically ill
patients.

Meta-analysis
Randomized
controlled trials

Human
Albumin,
Lactated
Ringers, Normal
Saline,
hydroyethyl
starch

Level I

Morbidity in
hospitalized
patients
receiving human
albumin: a metaanalysis of
randomized,
controlled trials.

Meta-analysis
randomized
control trials

Human
Level I
Albumin, 0.9
Normal Saline,
Lactated Ringers

Colloids versus
crystalloids for
fluid
resuscitation in
critically ill
children.
Albumin has no
benefit over
saline in the
critically ill.

Systematic
Review

Normal Saline,
Gelatin
Hydroxyethyl
Starch, Human
Albumin

Level I

Systematic
Review

Normal Saline,
4% Human
Albumin

Level I

Cochrane
Nursing Care
Field: Human
albumin for
intra-dialytic
hypotension in
haemodialysis
patients

Systematic
Review

Saline, Human
Level III
albumin,
Gelatin, Starches

2011
Vincent,
Navickis,
Wilkes
2004

Perel
&Roberts
2012

Petillia &
Ruokonen
2005
Andrews
2011
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Chapter 5: Discussion
Implementation of Recommendations
I presented the evidence-based recommendations from the literature review to the
Cardio-Thoracic Care Unit (CTCU) at Kettering Medical Center on June 11, 2013. My
audience included staff nurses and the Unit Educator. The presentation was completed
with a poster session. I provided handouts that included the “Literature Reviewed”
outlined in tables 1 and 2, the evidenced based recommendations, Appendix A, Appendix
B, and references.
The audience was concerned about articles that supported normal saline in the use
for all patients. The concern was that the generalizability of the normal saline might not
have been studied enough in depth for all patient types. Their concerns were eased by the
recommendations, as they specifically mention that patients who are experiencing
hypotension secondary to hypovolemia post-operatively, are on strict intake and output
regulation, and are at risk for post-perfusion syndrome, pulmonary hypertension, or
increased vascular permeability should receive 5% human albumin in place of normal
saline. Cost was not important to the audience as they felt their personal experience with
the effectiveness of 5% human albumin warrants the increased price. Overall, the
intended audience was pleased with the evidence-based recommendation and
recommendations that were presented.
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The next step to implement this recommendation in CTCU was to familiarize the
staff and physicians with the recommendation and to encourage the recommendations be
considered for every patient receiving fluid replacement therapy. I met with Dr. Pavlina
on August 2, 2013. Dr. Pavlina showed genuine interest in the topic. He currently favors
5% human albumin for fluid replacement in his patients whom need volume replacement
secondary to hypovolemia.
hypervolemia. He took the project handout and is going to read further into
this project. It will be my next step to follow up with his outlook of the recommendations
and further implement them into common practice into the CTCU.
Implications of Recommendations
The recommendation I presented to the CTCU would also be beneficial to nursing
and medical staff in the Cardiac Intensive Care Unit, surgical and cardiac step-down
units, and the Post-Anesthesia Care Unit at Kettering Medical Center and other regional
area hospitals. These are units that provide care to post-surgery adult patients that
experience hypotension secondary to hypovolemia. The implementation of the
recommendations in additional units could result in decreased unnecessary spending,
increased efficacy of the treatment, and increased safety of the patient population. The
extensive amount of research that was readily available indicates that this is an important
practice consideration worldwide and should not be limited to one patient setting. All
applicable units, which provide fluid replacement therapy, would benefit from these
recommendations.
Further Research & Practice
Choosing the correct therapy for each patient’s condition is an art form. We must
be able to use our critical thinking skills to select the best possible therapy for our
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patients. Research reviews, research studies, and meta-analyses allow us to see a more
diverse picture and choose the correct option for the dilemma at hand. The reviews and
articles that have been reviewed have similar content but conflicting conclusions. This is
a result of limited patient populations and a need for further research.
The use of normal saline in post-operative, trauma, hypovolemic, ARDS, dialysis,
and most other conditions is preferred over the use of 5% human albumin. Reviews that
failed to include patients of cardiac or vascular nature are not able to defend the use of
normal saline for these patients, as they can’t deflect the arguments of increased capillary
permeability with an increase of fluid shift with appropriate hemodynamic stability data.
Researchers must complete more studies that use a wide range of patient conditions,
including cardiac compromised patients, to determine the efficacy of 5% human albumin
compared to normal saline. This would increase the probability of having a more
generalizable recommendation.
Cost was only a factor for measurement in very few studies and the significance
of cost difference is only an added bonus for the use of normal saline. If there are added
benefits for the of human albumin such as decreased fluid intake, decreased mortality,
and increased cardiac output, then healthcare workers should not hesitate to use human
albumin should. Cost of the use of human albumin and the reimbursement value should
be analyzed in future reviews.
In conclusion, the successfully presented recommendation is an evidenced-based
practice. Health care providers must realize that it will be important for them to utilize
evidence-based practice. Two recommendations were outlined in this project and they
allowed for the contexts of the patient to determine the correct therapy. This individuality
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of the generalized recommendations allows for the efficacious, safe, and cost-effective
care patients deserve.
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APPENDIX A

Table 3
Levels of Evidence for Primary Research Question

Level I

Therapeutic
Studies:

Prognostic
Studies:

Diagnostic
Studies:

Investigating the
results of treatment

Investigating the
effect of a patient
characteristic on
the outcome of
disease

Investigating a
diagnostic test

- High quality
randomized trial
with statistically
significant
difference or no
statistically
significant
difference but
narrow confidence
intervals

-High quality
prospective
study4 (all

- Testing of
previously
developed
diagnostic criteria
on consecutive
patients (with
universally
applied reference
“gold” standard)

patients were
enrolled at the
same point in
their disease with
> 80% follow-up
of enrolled
patients)

-Systematic Review
-Systematic review2 of
2 of Level I RCTs
Level I studies
(and study results
were
homogenous3)

Level II

-Lesser quality
RCT (e.g. < 80%
follow-up, no
blinding, or
improper
randomization)

-Retrospective6
study- Untreated
controls from an
RCT
- Lesser quality
prospective study
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-Systematic
review2 of Level

Economic and
Decision
Analyses:
Developing an
economic or
decision model

- Sensible costs
and alternatives;
values obtained
from many
studies; with
multiway
sensitivity
analyses
- Systematic
review2 of
Level I studies

I studies

-Development of
diagnostic criteria
on consecutive
patients (with
universally
applied reference

- Sensible costs
and
alternatives;
values obtained
from limited
studies; with
multiway

-Prospective4
comparative
study5
-Systematic
review2 of Level
II studies or Level
I studies with
inconsistent results

Level III

- Case control
study7

(e.g., patients
enrolled at different
points in their
disease or <80%
follow-up).

“gold” standard)
- Systematic
review2 of Level
II studies

sensitivity
analyses
- Systematic
review2 of
Level II studies

- Systematic
review2 of Level II
studies

- Case control
study7

- Study of nonconsecutive
patients; without
consistently
applied reference
“gold” standard

-Retrospective6
comparative
study5

- Systematic review2 of
Level III studies

-Systematic
review2 of Level

- Analyses based
on limited
alternatives and
costs; and poor
estimates
- Systematic
review2 of Level
III studies

III studies

Level IV

-Case Series8

-Case Series

- Case-control
study

- Analyses with no
sensitivity
analyses

- Poor reference
standard
Level V

-Expert Opinion

-Expert Opinion

-Expert Opinion

-Expert Opinion

1. A complete assessment of quality of individual studies requires critical appraisal of all aspects of the
study design.
2. A combination of results from two or more prior studies.
3. Studies provided consistent results.
4. Study was started before the first patient enrolled.
5. Patients treated one way (e.g. cemented hip arthroplasty) com- pared with a group of patients treated
in another way (e.g. unce- mented hip arthroplasty) at the same institution.
6. The study was started after the first patient enrolled.
7. Patients identified for the study based on their outcome, called "cases"; e.g. failed total arthroplasty,
are compared to those who did not have outcome, called "controls"; e.g. successful total hip
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arthroplasty.
8. Patients treated one way with no comparison group of patients treated in another way.

(Rahman & Pukui, 2002)
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APPENDIX B

Table 4
Evidence-based validated grading rationale

Level of Evidence Grade

Criteria

A (Strong Scientific Evidence)

Statistically significant evidence of benefit from >2
properly randomized trials (RCTs), OR evidence
from one properly conducted RCT AND one
properly conducted meta-analysis, OR evidence
from multiple RCTs with a clear majority of the
properly conducted trials showing statistically
significant evidence of benefit AND with supporting
evidence in basic science, animal studies, or theory.

B (Good Scientific Evidence)

Statistically significant evidence of benefit from 1-2
properly randomized trials, OR evidence of benefit
from >1 properly conducted meta-analysis OR
evidence of benefit from >1 cohort/casecontrol/non-randomized trials AND with supporting
evidence in basic science, animal studies, or theory.
This grade applies to situations in which a well
designed randomized controlled trial reports
negative results but stands in contrast to the positive
efficacy results of multiple other less well designed
trials or a well designed meta-analysis, while
awaiting confirmatory evidence from an additional
well designed randomized controlled trial.

C (Unclear or Conflicting Scientific Evidence)

Evidence of benefit from >1 small RCT(s) without
adequate size, power, statistical significance, or
quality of design by objective criteria,* OR
conflicting evidence from multiple RCTs without a
clear majority of the properly conducted trials
showing evidence of benefit or ineffectiveness, OR
evidence of benefit from >1 cohort/casecontrol/non-randomized trials AND without
supporting evidence in basic science, animal studies,
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or theory, OR evidence of efficacy only from basic
science, animal studies, or theory.
D (Fair Negative Scientific Evidence)

Statistically significant negative evidence (i.e., lack
of evidence of benefit) from cohort/casecontrol/non-randomized trials, AND evidence in
basic science, animal studies, or theory suggesting a
lack of benefit. This grade also applies to situations
in which >1 well designed randomized controlled
trial reports negative results, notwithstanding the
existence of positive efficacy results reported from
other less well designed trials or a meta-analysis.
(Note: if there is >1 negative randomized controlled
trials that are well designed and highly compelling,
this will result in a grade of "F" notwithstanding
positive results from other less well designed
studies.)

F (Strong Negative Scientific Evidence)

Statistically significant negative evidence (i.e., lack
of evidence of benefit) from >1 properly
randomized adequately powered trial(s) of highquality design by objective criteria.*

Lack of Evidence†

Unable to evaluate efficacy due to lack of adequate
available human data.

* Objective criteria are derived from validated instruments for evaluating study quality, including the 5point scale developed by Jadad et al., in which a score below 4 is considered to indicate lesser quality
methodologically (Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay
HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled
Clinical Trials 1996; 17[1]:1-12).
† Listed separately in monographs in the "Historical or Theoretical Uses which Lack Sufficient
Evidence" section.
(Natural Standard, 2010)
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